Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

References

• RogerVLGoASLloyd-JonesDMHeart disease and stroke statistics – 2011 update: a report from the American Heart AssociationCirculation20111234e18e20921160056
   PubMed Web of Science ®Google Scholar
• Lloyd-JonesDMHuffmanMDKarmaliKNEstimating longitudinal risks and benefits from cardiovascular preventive therapies among Medicare patients: the million hearts longitudinal ASCVD risk assessment toolJ Am Coll Cardiol201769121617163627825770
   PubMedGoogle Scholar
• Pascual-GilSGarbayoEDiaz-HerraezPProsperFBlanco-PrietoMJHeart regeneration after myocardial infarction using synthetic biomaterialsJ Control Release2015203233825665866
   PubMed Web of Science ®Google Scholar
• BernsteinHSSrivastavaDStem cell therapy for cardiac diseasePediatr Res2012714 pt 249149922430385
   PubMedGoogle Scholar
• SegersVFLeeRTProtein therapeutics for cardiac regeneration after myocardial infarctionJ Cardiovasc Transl Res20103546947720607468
   PubMedGoogle Scholar
• GaffneyMMHynesSOBarryFO’BrienTCardiovascular gene therapy: current status and therapeutic potentialBr J Pharmacol2007152217518817558439
   PubMed Web of Science ®Google Scholar
• Action to Control Cardiovascular Risk in Diabetes Study GroupGersteinHCMillerMEEffects of intensive glucose lowering in type 2 diabetesN Engl J Med2008358242545255918539917
   PubMed Web of Science ®Google Scholar
• MarsoSPPoulterNRNissenSEDesign of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trialAm Heart J20131665823.e5830.e524176437
   PubMedGoogle Scholar
• NikolaidisLAMankadSSokosGGEffects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusionCirculation2004109896296514981009
   PubMed Web of Science ®Google Scholar
• Noyan-AshrafMHMomenMABanKGLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in miceDiabetes200958497598319151200
   PubMed Web of Science ®Google Scholar
• RichardsPParkerHEAdriaenssensAEIdentification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse modelDiabetes20146341224123324296712
   PubMed Web of Science ®Google Scholar
• InoueTInoguchiTSonodaNGLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic ratsAtherosclerosis2015240125025925818251
   PubMed Web of Science ®Google Scholar
• BuggerHAbelEDMolecular mechanisms of diabetic cardiomyopathyDiabetologia201457466067124477973
   PubMed Web of Science ®Google Scholar
• MarreMShawJBrandleMLiraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)Diabet Med200926326827819317822
   PubMed Web of Science ®Google Scholar
• BuseJBNauckMForstTExenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label studyLancet2013381986111712423141817
   PubMed Web of Science ®Google Scholar
• NauckMFridAHermansenKEfficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 studyDiabetes Care2009321849018931095
   PubMed Web of Science ®Google Scholar
• WuJKamalyNShiJDevelopment of multinuclear polymeric nanoparticles as robust protein nanocarriersAngew Chem Int Ed Engl201453348975897924990548
   PubMed Web of Science ®Google Scholar
• XiaoZFarokhzadOCAptamer-functionalized nanoparticles for medical applications: challenges and opportunitiesACS Nano2012653670367622574989
   PubMed Web of Science ®Google Scholar
• XiaoZCuS nanoparticles: clinically favorable materials for photothermal applications?Nanomedicine201493373375
   PubMedGoogle Scholar
• KamalyNXiaoZValenciaPMRadovic-MorenoAFFarokhzadOCTargeted polymeric therapeutic nanoparticles: design, development and clinical translationChem Soc Rev20124172971301022388185
   PubMed Web of Science ®Google Scholar
• GuFZhangLTeplyBAPrecise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymersProc Natl Acad Sci U S A200810572586259118272481
   PubMed Web of Science ®Google Scholar
• Noyan-AshrafMHShikataniEASchuikiIA glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesityCirculation20131271748523186644
   PubMed Web of Science ®Google Scholar
• RuvinovELeorJCohenSThe promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarctionBiomaterials201132256557820889201
   PubMed Web of Science ®Google Scholar
• RuvinovELeorJCohenSThe effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia modelBiomaterials201031164573458220206988
   PubMedGoogle Scholar
• YoshizumiTZhuYJiangHTiming effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarctionBiomaterials20168318219326774561
   PubMedGoogle Scholar
• PaulAHasanAKindiHAInjectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repairACS Nano2014888050806224988275
   PubMed Web of Science ®Google Scholar
• WangQYangHBaiAFunctional engineered human cardiac patches prepared from nature’s platform improve heart function after acute myocardial infarctionBiomaterials2016105526527509303
   PubMedGoogle Scholar
• SongMJangHLeeJRegeneration of chronic myocardial infarction by injectable hydrogels containing stem cell homing factor SDF-1 and angiogenic peptide Ac-SDKPBiomaterials20143582436244524378015
   PubMedGoogle Scholar
• KimJHJungYKimSHThe enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptidesBiomaterials201132266080608821636123
   PubMed Web of Science ®Google Scholar
• Santos-GallegoCGVahlTPGoliaschGSphingosine-1-phosphate receptor agonist fingolimod increases myocardial salvage and decreases adverse postinfarction left ventricular remodeling in a porcine model of ischemia/reperfusionCirculation20161331095496626826180
   PubMed Web of Science ®Google Scholar
• ChangMYYangYJChangCHFunctionalized nanoparticles provide early cardioprotection after acute myocardial infarctionJ Control Release2013170228729423665256
   PubMed Web of Science ®Google Scholar
• SabbahHNShimoyamaHKonoTEffects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fractionCirculation1994896285228598205701
   PubMed Web of Science ®Google Scholar
• DorVSabatierMDi DonatoMMontiglioFTosoAMaioliMEfficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scarsJ Thorac Cardiovasc Surg1998116150599671897
   PubMedGoogle Scholar
• D’AmoreAYoshizumiTLuketichSKBi-layered polyurethane – extracellular matrix cardiac patch improves ischemic ventricular wall remodeling in a rat modelBiomaterials201610711427579776
   PubMed Web of Science ®Google Scholar
• MarsoSPDanielsGHBrown-FrandsenKLiraglutide and cardiovascular outcomes in type 2 diabetesN Engl J Med2016375431132227295427
   PubMed Web of Science ®Google Scholar
• KavianipourMEhlersMRMalmbergKGlucagon-like peptide-1 (7–36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardiumPeptides200324456957812860201
   PubMedGoogle Scholar
• SatoKKamedaMYasuharaTNeuroprotective effects of liraglutide for stroke model of ratsInt J Mol Sci20131411215132152424177570
   PubMed Web of Science ®Google Scholar
• LeeJTanCYLeeSKKimYHLeeKYControlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarctionJ Control Release2009137319620219374930
   PubMed Web of Science ®Google Scholar
• WangLLiuYZhangWChenXYangTMaGMicrospheres and microcapsules for protein delivery: strategies of drug activity retentionCurr Pharm Des201319356340635223470006
   PubMed Web of Science ®Google Scholar
• WuJWilliamsGRBranford-WhiteCLiHLiYZhuLMLiraglutide-loaded poly(lactic-co-glycolic acid) microspheres: preparation and in vivo evaluationEur J Pharm Sci201692283827343696
   PubMed Web of Science ®Google Scholar
• FormigaFRPelachoBGarbayoESustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion modelJ Control Release20101471303720643169
   PubMed Web of Science ®Google Scholar
• Pascual-GilSSimon-YarzaTGarbayoEProsperFBlanco-PrietoMJTracking the in vivo release of bioactive NRG from PLGA and PEG-PLGA microparticles in infarcted heartsJ Control Release2015220pt A38839626546270
   PubMed Web of Science ®Google Scholar
• QiaoSZhaoYGengSA novel double-targeted nondrug delivery system for targeting cancer stem cellsInt J Nanomedicine2016116667667827994463
   PubMed Web of Science ®Google Scholar
• BiCWangAChuYIntranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatmentInt J Nanomedicine2016116547655927994458
   PubMed Web of Science ®Google Scholar
• JahanSTHaddadiAInvestigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticlesInt J Nanomedicine2015107371738426677326
   PubMed Web of Science ®Google Scholar
• Simon-YarzaTFormigaFRTamayoEPelachoBProsperFBlanco-PrietoMJPEGylated-PLGA microparticles containing VEGF for long term drug deliveryInt J Pharm20134401131822814223
   PubMedGoogle Scholar
• GrefRLuckMQuellecP‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorptionColloids Surf B Biointerfaces2000183–430131310915952
   PubMed Web of Science ®Google Scholar
• WattendorfUMerkleHPPEGylation as a tool for the biomedical engineering of surface modified microparticlesJ Pharm Sci200897114655466918306270
   PubMed Web of Science ®Google Scholar
• HaiderHAkbarSAAshrafMAngiomyogenesis for myocardial repairAntioxid Redox Signal20091181929194419361254
   PubMed Web of Science ®Google Scholar
• GyongyosiMKhorsandAZaminiSNOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia – subanalysis of the EUROINJECT-ONE multicenter double-blind randomized studyCirculation20051129I157I16516159809
   PubMed Web of Science ®Google Scholar